XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

FINANCIAL INSTRUMENTS (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2024
Investments, All Other Investments [Abstract] |
SCHEDULE OF CASH AND CASH EQUIVALENTS AND INVESTMENTS | SCHEDULE OF CASH AND CASH EQUIVALENTS AND INVESTMENTS
|  | As of March 31, 2024 |
|  | Cost |  |  | Unrealized Gain (Loss) |  |  | Fair Value |  |  | Cash and Cash Equivalents |
Cash |  | $ | 171,727 |  |  | $ | - |  |  |  |  |  |  | $ | 171,727 |
Level 1: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Money market funds |  |  | 4,113,616 |  |  |  | - |  |  | $ | 4,113,616 |  |  |  | 4,113,616 |
Total cash and cash equivalents |  | $ | 4,285,343 |  |  | $ | - |  |  | $ | 4,113,616 |  |  | $ | 4,285,343 |
|  | As of June 30, 2023 |
|  | Cost |  |  | Unrealized Gain (Loss) |  |  | Fair Value |  |  | Cash and Cash Equivalents |
Cash |  | $ | 242,271 |  |  | $ | - |  |  |  |  |  |  | $ | 242,271 |
Level 1: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Money market funds |  |  | 5,376,812 |  |  |  | - |  |  | $ | 5,376,812 |  |  |  | 5,376,812 |
Total cash and cash equivalents |  | $ | 5,619,083 |  |  | $ | - |  |  | $ | 5,376,812 |  |  | $ | 5,619,083 |
SCHEDULE OF FAIR VALUE OF CONTINGENT CONSIDERATION | As of March 31, 2024, the Company’s contingent consideration liabilities current and non-current balances were as follows: SCHEDULE OF FAIR VALUE OF CONTINGENT CONSIDERATION
|  | Contingent Consideration at Purchase Date |  |  | Consideration Paid |  |  | Changes in Fair Value |  |  | Fair Value |  |  | Contingent Consideration |
|  | As of March 31, 2024 |
|  | Contingent Consideration at Purchase Date |  |  | Consideration Paid |  |  | Changes in Fair Value |  |  | Fair Value |  |  | Contingent Consideration |
Level 3: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contingent consideration, current - S5D |  | $ | 2,060,300 |  |  | $ | (1,359,001 | ) |  | $ | (701,299 | ) |  | $ | - |  |  | $ | - |
Contingent consideration, current - BLI |  |  | 1,264,200 |  |  |  | - |  |  |  | 1,654,739 |  |  |  | 2,918,939 |  |  |  | 2,918,939 |
Contingent consideration, current - XRT |  |  | - |  |  |  | (499,288 | ) |  |  | 499,288 |  |  |  | - |  |  |  | - |
Total contingent consideration, current portion |  | $ | 3,324,500 |  |  | $ | (1,858,289 | ) |  | $ | 1,452,728 |  |  | $ | 2,918,939 |  |  | $ | 2,918,939 |
Level 3: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contingent consideration, non-current - S5D |  | $ | 7,108,900 |  |  | $ | (2,857,143 | ) |  | $ | (4,251,757 | ) |  | $ | - |  |  | $ | - |
Contingent consideration, non-current - BLI |  |  | 6,060,700 |  |  |  | - |  |  |  | (4,646,018 | ) |  |  | 1,414,682 |  |  |  | 1,414,682 |
Total contingent consideration, net of current portion |  | $ | 13,169,600 |  |  | $ | (2,857,143 | ) |  | $ | (8,897,775 | ) |  | $ | 1,414,682 |  |  | $ | 1,414,682 |
As of June 30, 2023, the Company’s contingent consideration liabilities current and non-current balances were as follows:
|  | Contingent Consideration at Purchase Date |  |  | Consideration Paid |  |  | Changes in Fair Value |  |  | Fair Value |  |  | Contingent Consideration |
|  | As of June 30, 2023 |
|  | Contingent Consideration at Purchase Date |  |  | Consideration Paid |  |  | Changes in Fair Value |  |  | Fair Value |  |  | Contingent Consideration |
Level 3: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contingent consideration, current - S5D |  | $ | 2,060,300 |  |  | $ | (1,359,001 | ) |  | $ | 1,207,501 |  |  | $ | 1,908,800 |  |  | $ | 1,908,800 |
Contingent consideration, current - BLI |  |  | 1,264,200 |  |  |  | - |  |  |  | 1,693,500 |  |  |  | 2,957,700 |  |  |  | 2,957,700 |
Contingent consideration, current - AUGGD |  |  | - |  |  |  | (568,571 | ) |  |  | 568,571 |  |  |  | - |  |  |  | - |
Contingent consideration, current - XRT |  |  | - |  |  |  | (331,786 | ) |  |  | 586,077 |  |  |  | 254,291 |  |  |  | 254,291 |
Total contingent consideration, current portion |  | $ | 3,324,500 |  |  | $ | (2,259,358 | ) |  | $ | 4,055,649 |  |  | $ | 5,120,791 |  |  | $ | 5,120,791 |
Level 3: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contingent consideration, non-current - S5D |  | $ | 7,108,900 |  |  | $ | (2,050,000 | ) |  | $ | (3,807,200 | ) |  | $ | 1,251,700 |  |  | $ | 1,251,700 |
Contingent consideration, non-current - BLI |  |  | 6,060,700 |  |  |  | - |  |  |  | (2,807,400 | ) |  |  | 3,253,300 |  |  |  | 3,253,300 |
Total contingent consideration, net of current portion |  | $ | 13,169,600 |  |  | $ | (2,050,000 | ) |  | $ | (6,614,600 | ) |  | $ | 4,505,000 |  |  | $ | 4,505,000 |

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments. + References No definition available. + Details
Name: | us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of cash, cash equivalents, and investments. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration